Fulfilling the potential of HER2-targeting in colorectal cancer

touchEXPERT OPINIONS for touchONCOLOGY Listen to three leading experts provide their insights on detection methods for HER2 amplification, as well as the clinical efficacy data for guideline-recommended HER2-targeted therapies and emerging HER2-targeted therapies for patients with metastatic colorectal cancer.  The experts Dr Andrew Wotherspoon - Royal Marsden Hospital, London, UK; Dr Andrea Cercek - Memorial Sloan Kettering Cancer Center, New York, NY, USA; Dr Elena Elez - Vall d'Hebron University Hospital, Barcelona, Spain; This touchPODCAST is for HCPs only. This activity is funded by an independent medical educational grant from Seagen Inc., and is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/fulfilling_the_potential_of_her2_targeting_in_crc/